Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-02-20 @ 12:19 PM
Study NCT ID:
NCT02722551
Status:
WITHDRAWN
Last Update Posted:
2018-01-09
First Post:
2016-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study
Sponsor:
Edwards Lifesciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Mitral Valve Regurgitation | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Mitral | View |
| None | Regurgitation | View |
| None | Insufficiency | View |
| None | Degenerative | View |
| None | Functional | View |
| None | Primary | View |
| None | Secondary | View |
| None | Organic | View |
| None | Transcatheter | View |
| None | TMVR | View |
| None | TMVI | View |
| None | Heart valve | View |
| None | Mitral valve | View |
| None | Transapical | View |
| None | Transfemoral | View |
| None | Transeptal | View |
| None | Severe | View |